Correlation between serum levels of endothelin-1 and disease severity in patients with neuromyelitis optica spectrum disorders

Immunobiology. 2020 May;225(3):151959. doi: 10.1016/j.imbio.2020.151959. Epub 2020 May 16.

Abstract

Aims: Neuromyelitis optica spectrum disorders (NMOSD) are aquaporin-4 antibody-mediated diseases of the central nervous system. Endothelin-1 (ET-1) is an inflammatory cytokine released by vascular endothelial cells and activated astrocytes. Previous studies have reported the aberrant expressions of cytokines/chemokines in patients diagnosed with NMOSD. However, the serum levels of ET-1 in NMOSD patients remain unknown. The purpose of this study was to measure the serum levels of ET-1 and other immune-related cytokines/chemokines in patients with NMOSD, and to investigate the correlation between serum ET-1 levels and clinical characteristics of NMOSD.

Methods: Thirty-eight patients with NMOSD and twenty-eight healthy controls (HCs) were recruited in this study. The serum concentrations of ET-1 and other cytokines/chemokines were measured, and their correlations to the clinical features of patients with NMOSD were analyzed.

Results: The serum levels of ET-1 in patients with NMOSD were significantly higher than those in HCs (P = 0.0001). The serum concentrations of ET-1 were positively correlated with the Expanded Disability Status Scale score (r = 0.428, P = 0.0183). High-dose intravenous methylprednisolone treatment significantly reduced the levels of ET-1 and interleukin (IL)-6 in blood, but significantly increased the serum concentrations of IL-10 in NMOSD patients. No correlations were found between serum ET-1 levels and the concentrations of other cytokines/chemokines in these patients.

Conclusion: ET-1 and IL-6 might exert pro-inflammatory effects in the pathogenesis of NMOSD, whereas IL-10 played an anti-inflammatory role in this process. ET-1 might be a potential biomarker for predicting the severity of NMOSD. However, the serum levels of ET-1 were not correlated with the changes of other cytokines/chemokines in patients with NMOSD. The involvement of ET-1 in the development of NMOSD needs to be further studied.

Keywords: Aquaporin-4 antibody; Endothelin-1; Inflammatory cytokines; Neuromyelitis optica spectrum disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers*
  • Cytokines / blood
  • Cytokines / metabolism
  • Disease Susceptibility
  • Endothelin-1 / blood*
  • Gene Expression Regulation
  • Humans
  • MicroRNAs / genetics
  • Monocytes / immunology
  • Monocytes / metabolism
  • Neuromyelitis Optica / blood*
  • Neuromyelitis Optica / diagnosis*
  • Neuromyelitis Optica / etiology
  • Prognosis
  • Severity of Illness Index
  • Signal Transduction

Substances

  • Biomarkers
  • Cytokines
  • Endothelin-1
  • MicroRNAs